Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry

Drug Testing and Analysis

Volumn 3, Issue 11-12, 2011, Pages 820-827

  Mareck, Ute ^a   Guddat, Sven ^a   Schwenke, Anne ^a   Beuck, Simon ^a   Geyer, Hans ^a   Flenker, Ulrich ^a   Elers, Jimmi ^b   Backer, Vibeke ^b   Thevis, Mario ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Doping; Salbutamol; Salbutamol glucuronide; Sport; Urine

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; GLUCOSE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

GLUCURONIDES; HUMAN URINE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; ORAL ADMINISTRATION; SALBUTAMOL; SALBUTAMOL GLUCURONIDE; URINE; URINE SAMPLE;

SCREENING;

GLUCURONIDE; SALBUTAMOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPING; DRUG DETERMINATION; DRUG METABOLISM; DRUG URINE LEVEL; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84855252995     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.367     Document Type: Article

References (32)

1. World Anti-Doping Agency. The 2011 Prohibited List. International Standard. Available at: [16 December 2010].
2. World Anti-Doping Agency. Decision Limits for the Confirmatory Quantification of Threshold Substances. Available at: [20 July 2010].
3. R. Berges, J. Segura, R. Ventura, X. De la Torre, M. Mas, M. Farre, K. D. Fitch, A. R. Morton, M. Ueki, in Recent Advances in Doping Analysis (6), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ), Sport & Buch Strauß, Köln, 1998, pp. 405-419.
4. R. Ventura, J. Segura, R. Berges, K. D. Fitch, A. R. Morton, S. Berruezo, C. Jimenez, Ther. Drug Monit. 2000, 22, 277.
5. R. Berges, J. Segura, X. De la Torre, R. Ventura, J. Chromatogr. B 1999, 723, 173.
6. R. Berges, J. Segura, R. Ventura, K. D. Fitch, A. R. Morton, M. Farre, M. Mas, X. De la Torre, Clin. Chem. 2000, 46, 1365.
7. G. Forsdahl, G. Gmeiner, J. Separ. Sci. 2004, 27, 110.
8. A. de la Cal, G. Munoz, S. Vargas, J. A. Munoz-Guerra, F. A. Rodriguez, C. Rodriguez, in Recent Advances in Doping Analysis (13), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ), Sportverlag Strauß, Köln, 2005, pp. 487-490.
9. J. Zhang, Y. Xu, X. Di, M. Wu, J. Chromatogr. B 2006, 831, 328.
10. M. K. Henze, H. Spahn-Langguth, W. Schänzer, in Recent Advances in Doping Analysis (9), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ), Sport & Buch Strauß, Köln, 2001, pp. 29-33.
11. M. K. Henze, Screening auf β2-Sympathomimetika in der Dopinganalytik Martin-Luther-Universität, Halle, 2001.
12. I. Bellahn, E. Nolteernsting, G. Opfermann, W. Schänzer, in Recent Advances in Doping Analysis (6), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ), Sport & Buch Strauß, Köln, 1998, pp. 489-496.
13. C. Schweizer, P. Mangin, M. Saugy, in Recent Advances in Doping Analysis (11), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ), Sport & Buch Strauß, Köln, 2003, pp. 289-293.
14. N. Halatcheva, E. Daneva, in Recent Advances in Doping Analysis (8), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ), Sport & Buch Strauß, Köln, 2000, pp. 189-196.
15. M. Donike, H. Geyer, A. Gotzmann, M. Kraft, F. Mandel, E. Nolteernsting, G. Opfermann, G. Sigmund, W. Schänzer, J. Zimmermann, in International Athletic Foundation World Symposium on Doping in Sport, (Eds: P. Bellotti, G. Benzi, A. Ljungqvist ), International Athletic Foundation, Florence, 1987, pp. 53-80.
16. H. Geyer, W. Schänzer, U. Mareck-Engelke, E. Nolteernsting, G. Opfermann, in Recent Advances in Doping Analysis (5), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ), Sport & Buch Strauß, Köln, 1997, pp. 99-101.
17. U. Mareck, M. Thevis, S. Guddat, A. Gotzmann, M. Bredehöft, H. Geyer, W. Schänzer, in Recent Advances in Doping Analysis (12), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ), Sport & Buch Strauß, Köln, 2004, pp. 65-68.
18. A. Gotzmann, M. Donike, in Proceedings, (Eds: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth ), Sport & Buch Strauß, Köln, 1992, pp. 281-284.
19. G. Gmeiner, T. Geisendorfer, J. Kainzbauer, M. Nikolajevic, in Recent Advances in Doping Analysis (9), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ), Sport & Buch Strauß, Köln, 2001, pp. 43-51.
20. M. Thevis, G. Sigmund, W. Schänzer, in Recent Advances in Doping Analysis (11), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ), Sport & Buch Strauß, Köln, 2003, pp. 303-307.
21. M. Thevis, W. Schänzer, J. Chromatogr. Sci. 2005, 43, 1.
22. U. Mareck, N. Haenelt, M. K. Parr, S. Guddat, A. Thomas, M. Thevis, W. Schänzer, in Recent Advances in Doping Analysis (15), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ), Sport & Buch Strauß, Köln, 2007, pp. 87-96.
23. T. Kuuranne, M. Kurkela, M. Thevis, W. Schänzer, M. Finel, R. Kostiainen, Drug Metab. Dispos. 2003, 31, 1117.
24. T. Kuuranne, A. Leinonen, W. Schänzer, M. Kamber, R. Kostiainen, M. Thevis, Drug Metab. Dispos. 2008, 36, 571.
25. L. E. Martin, J. C. Hobson, J. A. Page, C. Harrison, Eur. J. Pharmacol. 1971, 14, 183.
26. C. Lin, Y. Li, J. Mcglotten, J. B. Morton, S. Symchowicz, Drug Metab. Dispos. 1977, 5, 234.
27. S. Kromidas, Validierung in der Analytik, Wiley-VCH, Weinheim, 1999.
28. T. M. Annesley, Clin. Chem. 2003, 49, 1041.
29. J. Elers, L. Pedersen, J. Henninge, T. K. Lund, P. Hemmersbach, K. Dalhoff, V. Backer, Med. Sci. Sport Exer. 2010, 42, 244.
30. World Anti-Doping Agency, Identification Criteria for Qualitative Assays Incorporating Column Chromatography and Mass Spectrometry. Available at: [1 September 2010].
31. Validation of Analytical Procedures: Text and Methodology Q2 (R1). Available at: [27 November 2008].
32. W. Gottwald, Statistik für Anwender, Wiley-VCH, Weinheim, 2000.